NEW YORK (GenomeWeb News) – Almac Diagnostics said this week that it has launched a next-generation sequencing service to its portfolio, which also includes microarray, qPCR, and immunohistochemical offerings. Northern Ireland-based Almac said that the new NGS service will initially use the Illumina MiSeq platform.
Leica Biosystems has entered into a definitive agreement to acquire Aperio, expanding its digital pathology business. Terms of the acquisition were not disclosed.
GenScript this week said that it will participate in the Synthetic Yeast Genome Sc2.0 Project. The Piscataway, NJ-based firm said that it will complete the synthesis of a bulk length special yeast chromosome arm for the project, which is organized by a professor at Johns Hopkins University's School of Medicine.
The University of Nebraska Medical Center in Omaha has received around $142,000 from the University of Nebraska Foundation to purchase new medical research equipment, including a DNA sequencing instrument. The university didn't say which platform it intends to purchase.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.